Curaleaf (OTCMKTS:CURLF – Get Free Report) and OrthoPediatrics (NASDAQ:KIDS – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.
Earnings & Valuation
This table compares Curaleaf and OrthoPediatrics”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Curaleaf | $1.27 billion | 1.44 | -$231.07 million | ($0.13) | -60.31 |
| OrthoPediatrics | $236.35 million | 2.42 | -$39.65 million | ($1.68) | -13.07 |
OrthoPediatrics has lower revenue, but higher earnings than Curaleaf. Curaleaf is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Curaleaf has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.
Profitability
This table compares Curaleaf and OrthoPediatrics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Curaleaf | -2.62% | -0.88% | -0.26% |
| OrthoPediatrics | -15.72% | -8.10% | -5.54% |
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Curaleaf and OrthoPediatrics, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Curaleaf | 0 | 1 | 2 | 1 | 3.00 |
| OrthoPediatrics | 1 | 1 | 5 | 0 | 2.57 |
Curaleaf currently has a consensus price target of $6.00, indicating a potential downside of 23.47%. OrthoPediatrics has a consensus price target of $26.50, indicating a potential upside of 20.73%. Given OrthoPediatrics’ higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Curaleaf.
Insider & Institutional Ownership
0.0% of Curaleaf shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 32.5% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Curaleaf beats OrthoPediatrics on 8 of the 15 factors compared between the two stocks.
About Curaleaf
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.
About OrthoPediatrics
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
